Literature DB >> 32891766

Frequent acquisition of bedaquiline resistance by epidemic extensively drug-resistant Mycobacterium tuberculosis strains in Russia during long-term treatment.

Igor Mokrousov1, Gulnora Akhmedova2, Vladimir Molchanov3, Elena Fundovnaya2, Elena Kozlova2, Yulia Ostankova3, Alexander Semenov3, Natalia Maslennikova2, Dmitrii Leontev2, Viacheslav Zhuravlev4, Eugeni Turkin2, Anna Vyazovaya3.   

Abstract

Entities:  

Year:  2020        PMID： 32891766     DOI： 10.1016/j.cmi.2020.08.030

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  2 in total

Review 1.  Acquired bedaquiline resistance during the treatment of drug-resistant tuberculosis: a systematic review.

Authors:  Jahan Saeed Mallick; Parvati Nair; Elizabeth Tabitha Abbew; Armand Van Deun; Tom Decroo
Journal:  JAC Antimicrob Resist       Date:  2022-03-29

2.  Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug.

Authors:  Nirmal Kumar Jain
Journal:  Lung India       Date:  2022 Jul-Aug
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.